ABILIFY MAINTENA

Search images on Google      Product Monograph

Active Ingredients:

DIN: 02420872

Dosage Form(s): POWDER FOR SUSPENSION, SUSTAINED-RELEASE, KIT

Route(s) of Administration: INTRAMUSCULAR

Description: 200MG/ML AFTER RECONSTITUTION. SYRINGE AND DILUENT INCLUDED IN THE KIT

Schedule: Prescription

Company: OTSUKA PHARMACEUTICAL CO LTD

ATC:

Reference brand drug: Abilify

Pharmaceutical standard: MFR

 

External Links for Abilify Maintena:

Search on Google